🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

DiaSorin SpA (34D)

Frankfurt
Currency in EUR
108.250
-1.200(-1.10%)
Closed
34D Scorecard
Full Analysis
High shareholder yield
Fair Value
Day's Range
108.250108.250
52 wk Range
83.200109.800
Key Statistics
Edit
Bid/Ask
106.80 / 107.30
Prev. Close
109.45
Open
108.25
Day's Range
108.25-108.25
52 wk Range
83.2-109.8
Volume
1
Average Volume (3m)
33
1-Year Change
29.01%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
34D Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
106.880
Downside
-0.159%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 5 consecutive years
Show more

DiaSorin SpA Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Employees
3278
Market
Italy

Compare 34D to Peers and Sector

Metrics to compare
34D
Peers
Sector
Relationship
P/E Ratio
30.7x21.8x−0.7x
PEG Ratio
-0.470.00
Price/Book
3.6x2.6x2.6x
Price / LTM Sales
4.9x3.2x3.2x
Upside (Analyst Target)
-20.1%45.2%
Fair Value Upside
Unlock13.0%7.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.54
Dividend Yield
1.05%
Industry Median 1.26%
Annualised payout
1.1500
Paid annually
5-Years Growth
-
Growth Streak

FAQ

What Is the Diasorin (34D) Stock Price Today?

The Diasorin stock price today is 108.25.

What Stock Exchange Does Diasorin Trade On?

Diasorin is listed and trades on the Frankfurt stock exchange.

What Is the Stock Symbol for Diasorin?

The stock symbol for Diasorin is "34D."

Does Diasorin Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 1.05%.

What Is the Diasorin Market Cap?

As of today, Diasorin market cap is 5.71B.

What is Diasorin Earnings Per Share?

The Diasorin EPS is 3.54.

What Is the Next Diasorin Earnings Date?

Diasorin will release its next earnings report on 11 Mar 2025.

From a Technical Analysis Perspective, Is 34D a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.